IMAX (NYSE) insider Richard Gelfond sells shares totaling multi‑date proceeds
Rhea-AI Filing Summary
IMAX reported Form 144 filings indicating insider dispositions. The filing lists multiple cashless exercises and same-day sales tied to options originally acquired on 06/07/2016, and shows specific open-market sales on 03/10/2026, 04/02/2026, 04/06/2026, 04/10/2026, and 04/13/2026 by Richard Gelfond.
The recorded transactions list share amounts and gross proceeds per trade (e.g., 121,220 shares for $4,860,837.15 on 03/10/2026). This is a routine insider disposition report under Form 144 documenting sales rather than an operational or financial disclosure.
Positive
- None.
Negative
- None.
Insights
Routine Form 144 documents insider sales via cashless exercises and same-day sales.
The record shows a series of reported dispositions by Richard Gelfond with discrete trade dates and gross proceeds, consistent with reporting requirements for Section 16 insiders. The transactions are documented as cashless exercise/same-day sale and open-market sales.
These entries are administrative disclosures; they do not by themselves indicate company-level financial changes. Subsequent filings (Forms 4 or broker records) would provide additional detail on net holdings or any 10b5-1 plan mention.